Intellijoint Surgical received CE Mark approval for intellijoint HIP®, a 3D mini-optical navigation system. EU market launch is slated for 2018, and Australian Therapeutic Goods Administration approval is expected to occur in November 2017.
intellijoint HIP requires no pre- or intra-op imaging and can be used with implants from any manufacturer. It supports anterior, lateral and posterior approaches, with other applications under development. Earlier this year, the system achieved the milestone of use in >1,000 total hip replacements throughout Australia, Canada and the U.S. since commercial launch.
Intellijoint Surgical received CE Mark approval for intellijoint HIP®, a 3D mini-optical navigation system. EU market launch is slated for 2018, and Australian Therapeutic Goods Administration approval is expected to occur in November 2017.
intellijoint HIP requires no pre- or intra-op imaging and can be used with implants from any...
Intellijoint Surgical received CE Mark approval for intellijoint HIP®, a 3D mini-optical navigation system. EU market launch is slated for 2018, and Australian Therapeutic Goods Administration approval is expected to occur in November 2017.
intellijoint HIP requires no pre- or intra-op imaging and can be used with implants from any manufacturer. It supports anterior, lateral and posterior approaches, with other applications under development. Earlier this year, the system achieved the milestone of use in >1,000 total hip replacements throughout Australia, Canada and the U.S. since commercial launch.
Copy to clipboard 
